Species Differences in the Binding of [3H]Nitrobenzylthioinosine to the Nucleoside Transport System in Mammalian Central Nervous System Membranes: Evidence for Interconvertible Conformations of the Binding Site/Transporter Complex

Abstract: The binding of [3H]nitrobenzylthioinosine (NBMPR) to specific sites in CNS membranes was investigated using cortical tissue from a variety of mammalian species. Mass law analysis of the site‐specific binding of NBMPR data revealed that rat, mouse, guinea pig, and dog cortical membranes each contained an apparent single class of high‐affinity (KD 0.11–4.9 nM) binding sites for NBMPR; rabbit cortical membranes, however, exhibited two distinct classes of NBMPR binding sites with KD values of 0.4 nM and 13.8 nM. Dipyridamole, a potent inhibitor of nucleoside transport, produced a biphasic profile of inhibition of the binding of NBMPR to guinea pig, rabbit, and dog membranes (IC50 < 20 nM and IC50 > 6 μM for NBMPR binding sites displaying high and low affinity for dipyridamole, respectively). These results are indicative of heterogeneity of NBMPR binding sites in mammalian cortical membranes. Rat and mouse cortical membranes appear to possess only one type of NBMPR binding site, which has low affinity for dipyridamole. Detailed analysis of inhibitorinduced dissociation of NBMPR from its sites in each species led to the conclusion that these multiple forms of NBMPR binding sites are different conformations of a single site associated with the CNS nucleoside transport system, rather than two distinct sites. It is also suggested that the affinity of dipyridamole for each conformation of NBMPR site indicates the susceptibility of that conformation of the nucleoside transport system to inhibition by dipyridamole.

[1]  J. Hammond,et al.  [3H]Nitrobenzylthioinosine Binding to the Guinea Pig CNS Nucleoside Transport System: A Pharmacological Characterization , 1984, Journal of neurochemistry.

[2]  J. Hammond,et al.  Heterogeneity of high affinity nitrobenzylthioinosine binding sites in mammalian cortical membranes: multiple forms of central nervous system nucleoside transporters? , 1984, Canadian journal of physiology and pharmacology.

[3]  J. Young,et al.  Nucleoside transport. Photoaffinity labelling of high-affinity nitrobenzylthioinosine binding sites in rat and guinea pig lung. , 1984, Biochemical and biophysical research communications.

[4]  P. H. Barker,et al.  Nucleoside transport in heart: species differences in nitrobenzylthioinosine binding, adenosine accumulation, and drug-induced potentiation of adenosine action. , 1984, Canadian journal of physiology and pharmacology.

[5]  J. Young,et al.  Kinetics of nitrobenzylthioinosine binding to the human erythrocyte nucleoside transporter. , 1983, The Biochemical journal.

[6]  C. Cass,et al.  The kinetics of dissociation of the inhibitor of nucleoside transport, nitrobenzylthioinosine, from the high-affinity binding sites of cultured hamster cells. , 1983, The Biochemical journal.

[7]  R. Wohlhueter,et al.  Kinetic and thermodynamic studies on nitrobenzylthioinosine binding to the nucleoside transporter of Chinese hamster ovary cells. , 1983, Biochimica et biophysica acta.

[8]  A. Paterson,et al.  Benzodiazepine inhibition of nucleoside transport in human erythrocytes. , 1983, Biochemical pharmacology.

[9]  A. Paterson,et al.  Nucleoside transport in human erythrocytes. A simple carrier with directional symmetry in fresh cells, but with directional asymmetry in cells from outdated blood. , 1983, The Biochemical journal.

[10]  J. Hammond,et al.  Distribution of nucleoside transport sites in guinea‐pig brain , 1983, The Journal of pharmacy and pharmacology.

[11]  L. P. Davies,et al.  Diazepam inhibition of adenosine uptake in the CNS: lack of effect on adenosine kinase. , 1983, General pharmacology.

[12]  J. Montgomery,et al.  Initial rate kinetics and evidence for duality of mediated transport of adenosine, related purine nucleosides, and nucleoside analogues in L1210 cells. , 1983, Cancer research.

[13]  A. Paterson,et al.  Species differences in nucleoside transport. A study of uridine transport and nitrobenzylthioinosine binding by mammalian erythrocytes. , 1982, The Biochemical journal.

[14]  J. Patel,et al.  [3H]Nitrobenzylthioinosine Binding as a Probe for the Study of Adenosine Uptake Sites in Brain , 1982, Journal of neurochemistry.

[15]  C. Cass,et al.  Initial rate kinetics of the transport of adenosine and 4-amino-7-(beta-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidine (tubercidin) in cultured cells. , 1982, Cancer research.

[16]  S. Paul,et al.  Benzodiazepines are weak inhibitors of [3H]nitrobenzylthioinosine binding to adenosine uptake sites in brain , 1982, Neuroscience Letters.

[17]  J. Daly.  Adenosine receptors: targets for future drugs. , 1982, Journal of medicinal chemistry.

[18]  J. Young,et al.  Erythrocyte nucleoside transport: asymmetrical binding of nitrobenzylthioinosine to nucleoside permeation sites , 1982, The Journal of physiology.

[19]  J. Young,et al.  Nucleoside translocation in sheep reticulocytes and fetal erythrocytes: a proposed model for the nucleoside transporter , 1982, The Journal of physiology.

[20]  P. H. Barker,et al.  Inhibition of adenosine accumulation into guinea pig ventricle by benzodiazepines. , 1982, European journal of pharmacology.

[21]  T. Stone.  Cell-membrane receptors for purines , 1982, Bioscience reports.

[22]  Z. Arad,et al.  Comparative thermoregulation of four breeds of fowls (Callus domesticus), exposed to a gradual increase of ambient temperatures , 1982 .

[23]  J. Phillis,et al.  The effect of various centrally active drugs on adenosine uptake by the central nervous system. , 1982, Comparative biochemistry and physiology. C: Comparative pharmacology.

[24]  J. Phillis,et al.  Nucleoside transport in rat cerebral cortical synaptosomal membrane: a high affinity probe study. , 1982, The International journal of biochemistry.

[25]  T. Pazdernik,et al.  Uridine transport in concanavalin A- and lipopolysaccharide-activated mouse lymphocytes. , 1981, Biochemical pharmacology.

[26]  C. Cass,et al.  Binding of nitrobenzylthioinosine to high-affinity sites on the nucleoside-transport mechanism of HeLa cells. , 1981, The Biochemical journal.

[27]  J. Aono,et al.  Species Differences in Renal Vascular Effects of Dipyridamole and in the Potentiation of Adenosine Action by Dipyridamole , 1981, Journal of cardiovascular pharmacology.

[28]  T. Stone.  Physiological roles for adenosine and adenosine 5′-triphosphate in the nervous system , 1981, Neuroscience.

[29]  J. Phillis,et al.  Do benzodiazepines bind at adenosine uptake sites in CNS? , 1981, Life sciences.

[30]  C. Cass,et al.  Transport of nucleoside drugs in animal cells. , 1981, Pharmacology & therapeutics.

[31]  J. Young,et al.  Nucleoside transport in human and sheep erythrocytes. Evidence that nitrobenzylthioinosine binds specifically to functional nucleoside-transport sites. , 1980, The Biochemical journal.

[32]  A. Clanachan,et al.  Effect of adenosine uptake inhibition on the nature and potency of theophylline as a presynaptic adenosine receptor antagonist , 1980 .

[33]  R. Wohlhueter,et al.  Adenosine transport and metabolism in mouse leukemia cells and in canine thymocytes and peripheral blood leukocytes , 1979, Journal of cellular physiology.

[34]  N. Kolassa,et al.  Adenosine uptake by erythrocytes of man, rat and guinea-pig and its inhibition by hexobendine and dipyridamole. , 1975, Biochemical pharmacology.

[35]  N. Sano.  Enhancement of coronary vasodilating action of adenosine by dilazep and dipyridamole in the dog. , 1974, Japanese journal of pharmacology.

[36]  C. Cass,et al.  Mediated transport of nucleosides in human erythrocytes. Specific binding of the inhibitor nitrobenzylthioinosine to nucleoside transport sites in the erythrocyte membrane. , 1974, Biochimica et biophysica acta.

[37]  A. Paterson,et al.  Inhibitors of nucleoside and nucleotide metabolism. , 1972, Cancer chemotherapy reports. Part 2.

[38]  R. Furchgott.  The Classification of Adrenoceptors (Adrenergic Receptors). An Evaluation from the Standpoint of Receptor Theory , 1972 .

[39]  R. Goldie,et al.  A species difference in the uptake of adenosine by heart. , 1971, Biochemical pharmacology.

[40]  J. E. Oliver,et al.  An Attempted Synthesis of 4,5-Bis(dimethylamino)-1,2,3-thiadiazole , 1971 .

[41]  N. Kolassa,et al.  Species differences in action and elimination of adenosine after dipyridamole and hexobendine. , 1971, European journal of pharmacology.

[42]  J. Oliver,et al.  Nucleoside transport. I. A mediated process in human erythrocytes. , 1971, Canadian journal of biochemistry.

[43]  A. Stafford,et al.  Potentiation of adenosine and the adenine nucleotides by dipyridamole. , 1966, British journal of pharmacology and chemotherapy.

[44]  V. P. Whittaker,et al.  The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation. , 1962, Journal of anatomy.

[45]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.